🇺🇸 FDA
Patent

US 6365712

Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 &agr; subunit

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6365712 (Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 &agr; subunit) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00